Protagonist Therapeutics(DE:PGF)
€75.000.00 (0.00%)
DE:PGF
Protagonist Therapeutics earnings date
€75.00
At close:0.00 (0.00%)
Protagonist Therapeutics (PGF) Earnings Dates, Call Summary & Reports
1 Followers
Earnings Data
- Estimated Report Date
- Mar 02, 2027
- Period Ending
- 2026 (Q4)
- Consensus EPS Forecast
- -0.13
- Last Year’s EPS
- -0.62
TBA (Not Confirmed)
Same Quarter Last Year
Protagonist Therapeutics (DE:PGF) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
DE:PGF Q3 2026 Earnings Report
DE:PGF Upcoming Earnings
Protagonist Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
DE:PGF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.13- | -0.62 | ― | ― | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 2.742.75 | -0.56 | 595.16% (+3.30) | ― | ― | |
| Aug 05, 2026 | 2026 (Q2) | 1.982.05 | -0.49 | 516.36% (+2.54) | ― | ― | |
| May 05, 2026 | 2026 (Q1) | -0.420.04 | -0.17 | 126.32% (+0.21) | ― | ― | |
| Feb 25, 2026 | 2025 (Q4) | -0.51-0.62 | 1.77 | -134.85% (-2.39) | ― | ― | |
| Nov 06, 2025 | 2025 (Q3) | -0.56-0.56 | -0.48 | -14.81% (-0.07) | ― | ― | |
| Aug 06, 2025 | 2025 (Q2) | -0.52-0.49 | -0.45 | -10.00% (-0.04) | ― | ― | |
| Apr 30, 2025 | 2025 (Q1) | -0.17-0.17 | 2.92 | -105.67% (-3.08) | ― | ― | |
| Feb 21, 2025 | 2024 (Q4) | 1.031.77 | 0.39 | 350.00% (+1.38) | ― | ― | |
| Nov 07, 2024 | 2024 (Q3) | -0.52-0.48 | -0.52 | 6.90% (+0.04) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
DE:PGF Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 05, 2026 | €75.00 | €75.00 | +0.00% |
| Aug 05, 2026 | €75.00 | €75.00 | +0.00% |
| May 05, 2026 | €75.00 | €75.00 | +0.00% |
| Feb 25, 2026 | €75.00 | €75.00 | +0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Protagonist Therapeutics (DE:PGF) report earnings?
Protagonist Therapeutics (DE:PGF) is estimated to report earnings on Mar 02, 2027, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is DE:PGF EPS forecast?
DE:PGF EPS forecast for the fiscal quarter 2026 (Q4) is -0.13.
